GlassScriptPhysician profile
Jose A Bossbaly
NPI 1376551101
$23,216.40
in general payments reported to CMS, 2019-2025
73 companies · $1,903 in 2025
The $1,903 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,557 · 2020: $3,299 · 2021: $5,280 · 2022: $3,543 · 2023: $2,878 · 2024: $2,757 · 2025: $1,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,524 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,523.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,370.79 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $2,310.41 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $2,053.21 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,464.98 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Biohaven Pharmaceuticals, INC. | $1,200.00 | 2021 | |
| Amgen INC. | $971.95 | 2019-2025 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $945.56 | 2019-2022 | |
| Lilly USA, LLC | $839.29 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| E.R. Squibb & Sons, L.L.C. | $831.11 | 2019-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $720.50 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $699.80 | 2019-2025 | Trulance, Xifaxan, Cycloset |
| Astellas Pharma US INC | $691.03 | 2019-2023 | Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $605.45 | 2019-2025 | Rexulti |
| Pfizer INC. | $603.59 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $570.57 | 2019-2025 | Jardiance, Synjardy |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $552.69 | 2019-2022 | |
| Allergan, INC. | $414.04 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $391.95 | 2019-2025 | Verquvo, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $390.13 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $370.89 | 2019-2024 | |
| Esperion Therapeutics, INC. | $369.15 | 2020-2023 | Nexletol |
| Radius Health, INC. | $323.23 | 2019-2025 | Tymlos |
| Arbor Pharmaceuticals, INC. | $262.31 | 2019-2022 | |
| Amarin Pharma, INC. | $229.76 | 2019-2021 | |
| Abbott Laboratories | $229.49 | 2021-2025 | Freestyle Libre 3 |
| Intra-Sana Laboratories | $208.87 | 2024-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Teva Pharmaceuticals USA, INC. | $189.09 | 2020-2025 | Austedo Xr, Austedo Xr |
| Ironwood Pharmaceuticals, INC | $138.67 | 2020-2024 | Linzess |
| Lundbeck LLC | $134.95 | 2020-2025 | Rexulti |
| Philips North America LLC | $133.87 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $131.23 | 2020-2023 | Gvoke Hypopen |
| Dexcom, INC. | $115.08 | 2022-2025 | Dexcom G6 Transmitter |
| Nestle Healthcare Nutrition INC. | $109.27 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $92.11 | 2023-2025 | Aptiom, Gemtesa |
| Avanir Pharmaceuticals, INC. | $91.66 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $83.14 | 2019-2025 | Zoryve |
| Idorsia Pharmaceuticals US INC | $81.24 | 2022-2024 | Quviviq |
| Mylan Specialty L.P. | $79.29 | 2020-2023 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $77.10 | 2019-2021 | |
| Eisai INC. | $76.16 | 2020-2023 | |
| Mannkind Corporation | $74.46 | 2022 | |
| Biotronik INC. | $64.30 | 2020-2021 | |
| Exact Sciences Corporation | $62.17 | 2023-2025 | Cologuard Collection Kit |
| Medtronic Minimed, INC. | $61.75 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $61.58 | 2021-2024 | Dojolvi |
| Sunovion Pharmaceuticals INC. | $60.85 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.15 | 2022 | |
| Axsome Therapeutics, INC. | $45.40 | 2023-2024 | Auvelity |
| Inspire Medical Systems, INC. | $43.20 | 2024-2025 | Inspire |
| Azurity Pharmaceuticals, INC. | $38.78 | 2025 | Edarbi |
| Insightec,INC | $37.50 | 2024 | Exablate |
| Ardelyx, INC. | $37.34 | 2024-2025 | Ibsrela |
| Insulet Corporation | $36.04 | 2025 | Omnipod |
| Grifols USA, LLC | $31.78 | 2020-2022 | |
| Biogen, INC. | $31.47 | 2020-2021 | |
| Janssen Biotech, INC. | $29.10 | 2019 | |
| Althera Pharmaceuticals LLC | $24.85 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $22.32 | 2024 | Purified Cortrophin Gel |
| Edwards Lifesciences Corporation | $21.76 | 2023 | Sapien 3 Ultra Resilia |
| Opko Pharmaceuticals, LLC | $19.28 | 2021 | |
| Intuity Medical INC | $19.03 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Viatris Specialty LLC | $18.11 | 2025 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.58 | 2022 | |
| Corium, LLC | $16.15 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.01 | 2019 | |
| Nevro Corp. | $15.95 | 2022 | |
| Theracosbio, LLC | $15.87 | 2024 | Brenzavvy |
| Inari Medical, INC. | $15.48 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medicure Pharma INC. | $13.79 | 2024 | Zypitamag |
| Tonix Medicines, INC. | $13.77 | 2025 | Tonmya |
| Horizon Therapeutics Plc | $13.59 | 2020 | |
| Kaleo, INC. | $13.54 | 2019 | |
| Seqirus USA INC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Bossbaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.